Nippon Shinyaku Co., Ltd.;National Center of Neurology and Psychiatry
发明人:
申请号:
EP12861221.5
公开号:
EP2799548B1
申请日:
2012.12.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention provides a pharmaceutical agent which causes skipping of the 55th, 45th, 50th or 44th exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 55th, 45th, 50th or 44th exon in the human dystrophin gene.